Tech Company Financing Transactions
EPIRUS Biopharmaceuticals Funding Round
On 12/31/2012, EPIRUS Biopharmaceuticals secured $5 million in funding from Montreux Equity Partners and private investors.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Montreux Equity Partners (Daniel Turner)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
699 Boylston Street 11th Floor
Boston, MA 02199
USA
Boston, MA 02199
USA
Phone
Undisclosed
Website
Email Address
Overview
The biopharmacuticals industry is approaching an unprecedented biologics patent cliff, with emerging markets forging their own regulatory landscapes. EPIRUS is seizing the opportunity with a new business model that adapts to the changing dynamics and regulations of today's market conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Geoff Duyk
Chief Executive Officer
Amit Munshi
VP - Bus. Development
Gale Clark
VP - Bus. Development
Nick Plumeridge
VP - Manufacturing
Suman Patel
Browse more venture capital transactions:
Prev: 12/31/2012: Taulia venture capital transaction
Next: 12/31/2012: Management Health Solutions venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs